SCHEMBL9539031

SCHEMBL9539031

CC(C)n1c(-c2ccccc2)c2cc(Cl)ccc2nc1=S

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.44
MAPK1 P28482 3/20 0.44
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
HTT P42858 2/20 0.44
FABP3 P05413 2/20 0.43
FABP4 P15090 2/20 0.43
FABP5 Q01469 1/20 0.43
MAT2A P31153 1/20 0.43
LMNA P02545 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
ALDH1A1 P00352 3/20 0.41
USP2 O75604 1/20 0.41
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MAPT P10636 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
HPGD P15428 1/20 0.40
GAA P10253 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9539113 0.84 KDM4E (0.48) KDM4EMAPK1NPC1RAB9AHTT
SCHEMBL9539747 0.82 KDM4E (0.47) KDM4EMAPK1NPC1RAB9AHTT
SCHEMBL9539053 0.78 MAPT (0.50) KDM4EMAPK1NPC1RAB9AHTT
SCHEMBL9540062 0.70 KDM4E (0.51) KDM4EMAPK1NPC1RAB9AHTT
SCHEMBL22005102 0.70 ACLY (0.46) KDM4ENPC1RAB9AHTTLMNA
SCHEMBL9540153 0.68 KDM4E (0.50) KDM4EMAPK1HTTFABP3FABP4
SCHEMBL31268550 0.67 LMNA (0.46) KDM4EMAPK1NPC1RAB9AHTT
SCHEMBL13585806 0.67 KDM4E (0.58) KDM4EMAPK1FABP3FABP4FABP5
SCHEMBL5530192 0.67 MAPT (0.68) KDM4EMAPK1NPC1RAB9AHTT
SCHEMBL11601877 0.67 CASR (0.67)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1071917-A Quinazoline derivant as human immunodeficiency virus reversed transcriptive enzyme antagonist MERCK & CO INC (US) 1993-05-12 CN disclosed
EP-0530994-A1 Quinazoline derivatives as inhibitors of HIV reverse transcriptase MERCK & CO. INC. (US) 1993-03-10 EP disclosed
WO-1993004047-A1 QUINAZOLINE DERIVATIVES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE MERCK & CO., INC. (US) 1993-03-04 WO disclosed